Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
topic
Journal for ImmunoTherapy of Cancer
Special collections
JITC
Reviews
Email alerts
Reviews
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
Alice
Tzeng
,
Tony H
Tzeng
,
Moshe C
Ornstein
Journal for ImmunoTherapy of Cancer
Oct 2021,
9
(10)
e003473;
DOI:
10.1136/jitc-2021-003473
Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment
Feiya
Ma
,
Jensen
Vayalil
,
Grace
Lee
,
Yuqi
Wang
,
Guangyong
Peng
Journal for ImmunoTherapy of Cancer
Oct 2021,
9
(10)
e003217;
DOI:
10.1136/jitc-2021-003217
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
Jitka
Fucikova
,
An
Coosemans
,
Sandra
Orsulic
,
David
Cibula
,
Ignace
Vergote
,
Lorenzo
Galluzzi
,
Radek
Spisek
Journal for ImmunoTherapy of Cancer
Oct 2021,
9
(10)
e002873;
DOI:
10.1136/jitc-2021-002873
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
Nicholas P
Semenkovich
,
Jeffrey J
Szymanski
,
Noah
Earland
,
Pradeep S
Chauhan
,
Bruna
Pellini
,
Aadel A
Chaudhuri
Journal for ImmunoTherapy of Cancer
Jun 2023,
11
(6)
e006284;
DOI:
10.1136/jitc-2022-006284
Vaccinating against cancer: getting to prime time
Ryan
Chang
,
James L
Gulley
,
Lawrence
Fong
Journal for ImmunoTherapy of Cancer
Jun 2023,
11
(6)
e006628;
DOI:
10.1136/jitc-2022-006628
JAK inhibitors and COVID-19
Gabriel
Levy
,
Paola
Guglielmelli
,
Peter
Langmuir
,
Stefan N
Constantinescu
Journal for ImmunoTherapy of Cancer
Apr 2022,
10
(4)
e002838;
DOI:
10.1136/jitc-2021-002838
Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies
Luc
Magré
,
Monique M A
Verstegen
,
Sonja
Buschow
,
Luc J W
van der Laan
,
Maikel
Peppelenbosch
,
Jyaysi
Desai
Journal for ImmunoTherapy of Cancer
May 2023,
11
(5)
e006290;
DOI:
10.1136/jitc-2022-006290
Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets
Vladimir
Laletin
,
Pierre-Louis
Bernard
,
Cathy
Costa da Silva
,
Geoffrey
Guittard
,
Jacques A
Nunes
Journal for ImmunoTherapy of Cancer
May 2023,
11
(5)
e005845;
DOI:
10.1136/jitc-2022-005845
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
Kirit
Singh
,
Kelly M
Hotchkiss
,
Aditya A
Mohan
,
Jessica L
Reedy
,
John H
Sampson
,
Mustafa
Khasraw
Journal for ImmunoTherapy of Cancer
Nov 2021,
9
(11)
e003679;
DOI:
10.1136/jitc-2021-003679
T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells
Yasmin
Nouri
,
Robert
Weinkove
,
Rachel
Perret
Journal for ImmunoTherapy of Cancer
Nov 2021,
9
(11)
e003065;
DOI:
10.1136/jitc-2021-003065
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
Partner Collections and Supplements
Scientific Meetings and Conference Reports
Special collections
COVID-19
(45)
Editor's choice
JITC
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Aging and diversity, equity, and inclusion (DEI) with regard to cancer immunotherapy and understudied populations
Basic Tumor Immunology
(570)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(997)
Commentary/Editorials
(154)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(56)
Guidelines and Consensus Statements
(53)
Imaging and Immunotherapy
(9)
Immune Cell Therapies and Immune Cell Engineering
(249)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(443)
Liquid Biopsies
(10)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(152)
Reviews
(245)
The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)
(1)
Open access
(5067)
Press releases
(4)
